Home » Posts tagged with » Germany
Permira to acquire Spanish pharma company Neuraxpharm from Apax Partners

Permira to acquire Spanish pharma company Neuraxpharm from Apax Partners

Permira, a UK-based private equity firm, said that a company backed by its funds has agreed to acquire Neuraxpharm, a specialty pharma company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the deal were not revealed. Based in Spain and Germany, Neuraxpharm is engaged […]

BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates

Biopharmaceutical New Technologies (BioNTech) has agreed to acquire a GMP certified manufacturing facility in Marburg, Germany from Novartis to expand the production capacity of its BNT162 COVID-19 vaccine candidates. The financial terms of the deal were not revealed by the parties. BioNTech said that the production capacity of its five mRNA COVID-19 vaccine candidates under […]

Continue reading …
Takeda to sell select non-core assets to Cheplapharm for $562m

Takeda Pharmaceutical has agreed to sell a portfolio of certain non-core prescription pharma products sold mainly in Europe and Canada to German pharma company Cheplapharm for about $562 million. The portfolio to be offloaded to Cheplapharm is made up of non-core prescription pharma products in a range of therapeutic segments. This includes cardiovascular/metabolic and anti-inflammatory […]

Continue reading …
PCI Pharma Services to open new clinical center of excellence in Berlin

PCI Pharma Services, a drug development solutions provider, is set to expand its global clinical trial services with a new clinical center of excellence (COE) at its Berlin location in Germany. The pharma and biopharma outsourcing solutions provider said that the new center will enable it to grow its clinical supply-chain network into continental Europe […]

Continue reading …
Haemonetics acquires German medical technology manufacturer enicor

Haemonetics acquisition of enicor : US blood management company Haemonetics has acquired Germany-based medical technology manufacturer enicor, which manufactures the ClotPro whole blood coagulation testing system. Financial terms of the deal were not disclosed. The ClotProblood coagulation testing system is said to be an advanced viscoelastic diagnostic device that delivers more assays than other hemostasis […]

Continue reading …
AdaptHealth to acquire Patient Care Solutions from McKesson

AdaptHealth, a US home medical equipment provider (HME provider), has agreed to acquire the Patient Care Solutions business from German healthcare and pharma company McKesson. Patient Care Solutions offers wound care supplies, urological supplies, ostomy supplies, incontinence supplies, breast pumps, and diabetic care supplies to patients across 50 states in the US. For the 12 […]

Continue reading …
Takeda Pharmaceutical opens €130m vaccine manufacturing plant in Germany

Takeda Pharmaceutical Company opened a new €130 million vaccine manufacturing plant in Germany at Singen to produce TAK-003, its dengue vaccine candidate. The Singen vaccine manufacturing facility will be used for the formulation, fill, finish and secondary packaging of the TAK-003 dengue vaccine candidate starting with the packaging line. The vaccine plant employs up to […]

Continue reading …
Boehringer Ingelheim to initiate phase 2 trial of BI 456906 in obesity, diabetes

German drugmaker Boehringer Ingelheim will initiate Phase 2 clinical trial of dual-acting GLP-1/glucagon agonist BI 456906 in obesity and diabetes in late 2019. The compound in-licensed from Zealand Pharma is derived from the natural gut hormone oxyntomodulin and activates both the GLP-1 and glucagon receptors to control metabolic activities. The dual agonist BI 456906 with […]

Continue reading …
Bayer to divest animal health business to Elanco for $7.6bn

US-based veterinary pharmaceuticals producer Elanco Animal Health has agreed to acquire German drug giant Bayer’s animal health business for $7.6 billion, financed by a combination of 70% cash and 30% equity. The transaction, which enhances emerging market presence and strengthens cattle business, will strengthen Elanco’s Innovation, Portfolio, and Productivity (IPP) strategy, creating the second largest […]

Continue reading …
Italian pharma company Zambon acquires Breath Therapeutics for €140m

Zambon acquisition of Breath Therapeutics : Italian pharma company Zambon has acquired German biopharma company Breath Therapeutics and its subsidiaries for €140 million, which can potentially go up to total €500 million based on the latter’s achievement of certain regulatory and sales milestones. Breath Therapeutics, which is based in Munich as well as Menlo Park […]

Continue reading …
Page 1 of 212